Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

QUBT Stock Outpaces the Market but is the Rally Sustainable?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a130cb51-4ded-41be-b600-b83e2078ad65.png
QUBT Stock Outpaces the Market but is the Rally Sustainable?

Quantum Computing Inc. QUBT has taken a major step toward commercial scalability with the full construction and early-stage operation of its Quantum Photonic Chip Foundry in Tempe, AZ. This facility

Merck Faces Multiple Challenges: Will It Steer Through Successfully?
Merck Faces Multiple Challenges: Will It Steer Through Successfully?

Merck MRK is expected to face several hurdles over the next few years that could affect its long-term growth trajectory, starting with the anticipated loss of exclusivity of its blockbuster PD-L1

Will Recent Label Expansions of Opdivo Help BMY Gain Momentum?
Will Recent Label Expansions of Opdivo Help BMY Gain Momentum?

Bristol Myers’ BMY growth portfolio primarily comprises Opdivo, Orencia, Yervoy, Reblozyl, Opdualag, Abecma, Zeposia, Breyanzi, Camzyos, Sotyku, Krazati and others.

Among these, immuno-oncology drug

Verona Pharma Stock Jumps 20% on $10B Buyout Offer From MerckPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck

Verona Pharma VRNA has signed a definitive agreement with pharma bigwig Merck MRK. Per the terms, the pharma giant will acquire all outstanding shares of VRNA for $107 per American depositary share

GSK's Specialty Medicines Unit on a Strong Footing: Here's Why
GSK's Specialty Medicines Unit on a Strong Footing: Here's Why

GSK plc’s GSK Specialty Medicines segment includes medicines that prevent and treat diseases like HIV, cancer, asthma and immune-inflammation diseases like lupus. Specialty Medicines now represents

Wix, Monotype to Expand Font Library & Empower Creators Globally
Wix, Monotype to Expand Font Library & Empower Creators Globally

Wix.com Ltd. (WIX) recently partnered with Monotype Imaging Inc., a renowned name in typography and font technology. The collaboration significantly expands Wix’s font library, offering users,

Company News for Jul 9, 2025Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Company News for Jul 9, 2025
  • U.S-based copper mining company Freeport-McMoRan Inc. FCX gained 2.5% on Trump’s tariff threats on imported copper.
  • Shares of Moderna, Inc. MRNA gained 8.8% on leading medical organizations filing
Stock Market News for Jul 9, 2025Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
Stock Market News for Jul 9, 2025

Wall Street closed mixed on Tuesday, continuing to sway on tariff concerns. Investor mood was grim on President Trump expanding the global trade war to imported copper, semiconductors and

Volaris Reports Decrease in Consolidated Load Factor for June
Volaris Reports Decrease in Consolidated Load Factor for June

Mexican carrier Controladora Vuela Compañía de Aviación VLRS, or Volaris, recently reported a year-over-year increase in revenue passenger miles (RPMs: a measure of air traffic) for June 2025.

China's 100K Ultra-Fast Charger Plan: BYD, TSLA & Others in Focus
China's 100K Ultra-Fast Charger Plan: BYD, TSLA & Others in Focus

China is literally charging ahead when it comes to preparing for an electric future. This week, the country unveiled an ambitious plan to build 100,000 ultra-fast public EV chargers by 2027—a move

Fastenal (FAST) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Fastenal (FAST) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

In its upcoming report, Fastenal (FAST) is predicted by Wall Street analysts to post quarterly earnings of $0.28 per share, reflecting an increase of 12% compared to the same period last year

Ahead of FB Financial (FBK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Ahead of FB Financial (FBK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Analysts on Wall Street project that FB Financial (FBK) will announce quarterly earnings of $0.89 per share in its forthcoming report, representing an increase of 6% year over year. Revenues are

UPS vs. FDX: Which Parcel Delivery Company Has an Edge Now?
UPS vs. FDX: Which Parcel Delivery Company Has an Edge Now?

United Parcel Service UPS and FedEx FDX are two well-known global package delivery companies. Both these heavyweights offer a wide range of shipping services, including domestic and international

Crown Castle Stock Gains 13% Year to Date: Will the Trend Last?
Crown Castle Stock Gains 13% Year to Date: Will the Trend Last?

Crown Castle CCI shares have risen 13% year to date, outperforming the industry's upside of 3.7%.

Crown Castle’s efforts to augment its tower business bode well for growth amid rising wireless

JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?

Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified healthcare portfolios. J&J operates primarily through its

Credo Technology Surges 144% in 3 Months: Is the Stock Still a Buy?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/32e7a10f-efd0-424a-861f-2f3e0bb7ce02.png
Credo Technology Surges 144% in 3 Months: Is the Stock Still a Buy?

Credo Technology Group Holding Ltd CRDO has been on a tear, with the stock appreciating 144.2% over the past three months. Riding on momentum fueled by AI proliferation and increasing demand for

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

Here's an eye-opening statistic: older Americans are more afraid of running out of money than of death itself.

And retirees have good reason to be worried about making their assets last. People are

Salesforce's Data Cloud ARR Soars 120%: Is It the Next Sales Lever?Photo, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Salesforce's Data Cloud ARR Soars 120%: Is It the Next Sales Lever?

Salesforce, Inc.’s CRM Data Cloud is showing rapid growth, with annual recurring revenues (ARR) soaring 120% year over year to cross the $1 billion mark in the first quarter of fiscal 2025. The

Top Big Data Stocks for Savvy Investors on the Growing Analytics Trend
Top Big Data Stocks for Savvy Investors on the Growing Analytics Trend

An updated edition of the May 23, 2025 article.

Big Data specifically refers to massive amounts of information generated daily from various sources, such as online shopping, sensors, social media

JPMorgan Q2 Earnings on the Deck: A Smart Buy or Risky Bet?Photo, wide shot, wide-angle lens,  Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
JPMorgan Q2 Earnings on the Deck: A Smart Buy or Risky Bet?

JPMorgan JPM is scheduled to kickstart second-quarter 2025 earnings on July 15. As the largest American bank, its earnings are closely watched for insights into the financial sector, often serving

Pinterest, Inc. (PINS) Is a Trending Stock: Facts to Know Before Betting on It
Pinterest, Inc. (PINS) Is a Trending Stock: Facts to Know Before Betting on It

Pinterest (PINS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Is Trending Stock The Boeing Company (BA) a Buy Now?
Is Trending Stock The Boeing Company (BA) a Buy Now?

Boeing (BA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over

Investors Heavily Search The Progressive Corporation (PGR): Here is What You Need to Know
Investors Heavily Search The Progressive Corporation (PGR): Here is What You Need to Know

Progressive (PGR) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Investors Heavily Search Abercrombie & Fitch Company (ANF): Here is What You Need to Know
Investors Heavily Search Abercrombie & Fitch Company (ANF): Here is What You Need to Know

Abercrombie & Fitch (ANF) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the

First Solar, Inc. (FSLR) is Attracting Investor Attention: Here is What You Should Know
First Solar, Inc. (FSLR) is Attracting Investor Attention: Here is What You Should Know

First Solar (FSLR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in